LI_182760
|
Pages: NA
|
Jun 2018 | 947 Views
|
![]() ![]() |
|
Author's :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
![]() ![]() ![]() |
![]() ![]() |
Anti-malarial drugs are medications used for the treatment and prevention of malaria infection. They are also known as anti-malarials. These drugs are used for routine intermittent treatment of specific groups in endemic regions. Anti-malarial drugs are also used for prevention of infection in individuals who travel or visit a malaria-endemic region. Efficacious antimalarial therapy not only reduces the morbidity and mortality of malaria, but also reduces the risk of resistance to antimalarial drugs.
The global anti-malarial drugs market is gradually developing due to the surge in prevalence rate of malaria globally. Favorable government regulations, development of multi-drug resistance (MDR), and increase in research, development, and innovation in terms of anti-malaria therapeutics is anticipated to supplement market growth. However, possible side effects of anti-malaria drugs such as anxiety, dizziness insomnia, and others impede the growth of this market.
The global antimalarial drug market is segmented on the basis of drug type, malaria type, mechanism of action, distribution channel, and geography. Based on drug type, it is divided into quinine, chloroquine, pyrimethamine, amodiaquine, proguanil, mefloquine, sulfonamide, artemisinin & derivatives, atovaquone, primaquine, halofantrine, doxycycline, and clindamycin. On the malaria type, it is classified into plasmodium falciparum, plasmodium vivax, plasmodium malariae and plasmodium ovale. By mechanism of action, it is bifurcated into resistance and prevention. Furthermore, by distribution channel the antimalarial drug market is categorized into hospital pharmacy, retail pharmacy, e-commerce, and others. By geography, this market is analyzed across North America, Europe, Asia Pacific, and LAMEA. These regions are further analyzed across the globe at country level to determine the market size and forecast for each segment and sub segment of the market.
Comprehensive competitive analysis and profiles of major market players such as GlaxoSmithKline Plc, Ranbaxy Laboratories, Zydus Cadila, Alvizia Health Care, Bayer AG, Pfizer, Inc., Ipca Laboratories Ltd, Merck KGaA, F. Hoffmann-La Roche AG, and Novartis AG are also provided in this report.
Key Benefits
* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.
Enterprice
License/PDF
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high level data integrity, accurate analysis and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.